bpc-157 human clinical trials 2026 — the most prescribed peptide you've never seen in a trial. 30 total subjects. Zero RCTs. A Phase 1 that was registered, enrolled, and then quietly canceled with no BPC-157 is being marketed as
Description
BPC-157 is dosed in micrograms (typically 250500 mcg per injection), so each 5 mg/5 ml vial covers many more individual doses than a semaglutide vial of the same volume
Community protocols describe gentle swirling not shaking to avoid degradation, with storage at 28C and use within 28 days
Unless you have full spectrum lighting that we don't know about
My husband has had Bells Palsy 3 times (he is 70)
